Company intelligence / Profile preview

LifeVac Canada

Ontario, Canada

Ownership: Private
Development stage: Other

Overview

LifeVac is a non-powered, non-invasive airway clearance device for choking emergencies when standard protocols fail. The company reports over 4,000 lives saved globally as of 2025, with approximately 1,700 saves in 2024 alone.[7] The device uses a patented one-way valve mechanism to create negative pressure suction and has been presented at multiple medical conferences including the American College of Emergency Physicians and International Journal of Clinical Skills.[8]

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on LifeVac Canada.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeVac Canada.

Explore the full profile